|

enfortumab vedotin (EV) Clinical Trials

2 actively recruiting trials across 1 location

No change since July 2026

Pipeline

Phase 1: 1Phase 2: 1

Top Sponsors

  • Peking University Third Hospital1
  • Generate Biomedicines1

Indications

  • Cancer2
  • Advanced Urothelial Cancer1
  • Muscle Invasive Bladder Cancer (MIBC)1
  • Metastatic Urothelial Carcinoma1

Other1 trial

EV + Toripalimab vs GC as Neoadjuvant Therapy in Locally Advanced/High-Risk MIBC
Phase 2

Duarte, California1 trial

Study of GB-4362 With Enfortumab Vedotin and Pembrolizumab for Advanced Urothelial Cancer

City of Hope

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.